Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.

Arnsten AF.

CNS Drugs. 2009;23 Suppl 1:33-41. doi: 10.2165/00023210-200923000-00005. Review.

PMID:
19621976
2.

The use of α-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder.

Arnsten AF.

Expert Rev Neurother. 2010 Oct;10(10):1595-605. doi: 10.1586/ern.10.133. Review.

3.

Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function.

Brennan AR, Arnsten AF.

Ann N Y Acad Sci. 2008;1129:236-45. doi: 10.1196/annals.1417.007. Review.

4.

Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.

Arnsten AF, Pliszka SR.

Pharmacol Biochem Behav. 2011 Aug;99(2):211-6. doi: 10.1016/j.pbb.2011.01.020. Epub 2011 Feb 2. Review.

5.

Catecholamine influences on dorsolateral prefrontal cortical networks.

Arnsten AF.

Biol Psychiatry. 2011 Jun 15;69(12):e89-99. doi: 10.1016/j.biopsych.2011.01.027. Epub 2011 Apr 13. Review.

6.

Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.

Arnsten AF.

J Clin Psychiatry. 2006;67 Suppl 8:7-12. Review.

8.

Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions.

Arnsten AF, Li BM.

Biol Psychiatry. 2005 Jun 1;57(11):1377-84. Review.

PMID:
15950011
9.

Catecholamine regulation of the prefrontal cortex.

Arnsten AF.

J Psychopharmacol. 1997;11(2):151-62. Review.

PMID:
9208378
10.

Stimulants: Therapeutic actions in ADHD.

Arnsten AF.

Neuropsychopharmacology. 2006 Nov;31(11):2376-83. Epub 2006 Jul 19. Review.

12.

Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd).

Alamo C, López-Muñoz F, Sánchez-García J.

Actas Esp Psiquiatr. 2016 May;44(3):107-12. Epub 2016 May 1. Review.

13.

A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder.

Schmeichel BE, Zemlan FP, Berridge CW.

Neuropharmacology. 2013 Jan;64:321-8. doi: 10.1016/j.neuropharm.2012.07.005. Epub 2012 Jul 11.

14.

Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder.

Frank MJ, Santamaria A, O'Reilly RC, Willcutt E.

Neuropsychopharmacology. 2007 Jul;32(7):1583-99. Epub 2006 Dec 13.

15.

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.

Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW.

Neuropsychopharmacology. 2002 Nov;27(5):699-711.

16.

Pharmacological and therapeutic directions in ADHD: Specificity in the PFC.

Levy F.

Behav Brain Funct. 2008 Feb 28;4:12. doi: 10.1186/1744-9081-4-12.

17.

Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder.

Berridge CW, Devilbiss DM.

Biol Psychiatry. 2011 Jun 15;69(12):e101-11. doi: 10.1016/j.biopsych.2010.06.023. Epub 2010 Sep 26. Review.

18.

The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder.

Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW.

Biol Psychiatry. 2011 Jun 15;69(12):e145-57. doi: 10.1016/j.biopsych.2011.02.036. Epub 2011 May 6. Review.

PMID:
21550021
19.

Guanfacine for the treatment of cognitive disorders: a century of discoveries at Yale.

Arnsten AF, Jin LE.

Yale J Biol Med. 2012 Mar;85(1):45-58. Epub 2012 Mar 29. Review.

20.

Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.

Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, Hamilton C, Spencer RC.

Biol Psychiatry. 2006 Nov 15;60(10):1111-20. Epub 2006 Jun 23.

PMID:
16806100

Supplemental Content

Support Center